10.2337/dc15-0293

Comment on Genuth. Should Sulfonylureas Remain an Acceptable First-Line Add-on to Metformin Therapy in Patients With Type 2 Diabetes? No, It’s Time to Move On! Diabetes Care 2015;38:170–175

Abstract

Abstract is not available.

    Similar works

    Full text

    thumbnail-image
    Last time updated on 12/10/2019

    This paper was published in Crossref.

    Having an issue?

    Is data on this page outdated, violates copyrights or anything else? Report the problem now and we will take corresponding actions after reviewing your request.